Every year on September 15th we join the myotonic dystrophy community in recognizing International Myotonic Dystrophy Day.
What drew me to Dyne was the company’s commitment to developing revolutionary therapies that target muscle tissue with unprecedented precision. It’s a joy to lead a research team with such unwavering dedication to transforming the lives of people and families living with serious muscle diseases.